Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
World Journal of Urology|July 26, 2013
Urodynamic characterization of lower urinary tract symptoms in men less than 40 years of ageAsha E Jamzadeh, Donghua Xie, Melissa Laudano, et al.
Urology|March 31, 2009
PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancerSteven A Kaplan, Claus G Roehrborn, Alan G Meehan, et al.
Urology|February 2, 2016
Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral AnticoagulationDaniel J Lee, Malte Rieken, Joshua Halpern, et al.
The Journal of Urology|July 22, 2008
Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trialSteven A Kaplan, Claus G Roehrborn, John D McConnell, et al.
The Journal of Urology|April 21, 2009
Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trialBrian T Helfand, Anne K Mongiu, Claus G Roehrborn, et al.
The Journal of Urology|December 1, 2020
Male Voiding Behavior: Insight from 19,824 At-Home Uroflow ProfilesStephen J Summers, Joseph M Armstrong, Steven A Kaplan, et al.
European Urology|March 13, 2012
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasiaMauro Gacci, Giovanni Corona, Matteo Salvi, et al.
Prostate Cancer and Prostatic Diseases|April 13, 2024
Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPHGian Maria Busetto, Riccardo Lombardo, Cosimo De Nunzio, et al.
BJU International|April 19, 2008
Beyond the cluster: methodological and clinical implications in the Boston Area Community Health survey and EPIC studiesRaymond C Rosen, Karin S Coyne, David Henry, et al.
World Journal of Urology|February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year resultsNeal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Pageof 20